Medicover Hospitals S.R.L.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials

Phase

• Phase 21 trial
• Phase 2/31 trial

Status

• Recruiting2 trials

Lead sponsor

• Eikon Therapeutics1 trial
• Shanghai Henlius Biotech1 trial

Running trials

• Recruiting

  A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

  NCT07365319· Phase 2/3· Eikon Therapeutics· Source

• Recruiting

  A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

  NCT06907615· Phase 2· Shanghai Henlius Biotech· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer2 recruiting